Summary:
This webinar will focus on key topics related to Alzheimer’s disease, including biomarkers and early-onset Alzheimer’s. You’ll learn what biomarkers are, how they’re measured, and how they’re used in understanding the disease. We’ll also discuss early-onset Alzheimer’s disease, which affects people under 65, and why early detection is crucial for managing the disease.
The session will also cover the DIAN-TU-002 study, a research trial focused on people with a rare gene mutation that causes Alzheimer’s. This study is testing whether early treatment can prevent the buildup of amyloid beta, a protein that forms clumps in the brain and contributes to Alzheimer’s symptoms. You’ll learn about the drug treatment being tested, how the study works, who can participate, and why this research is important for future Alzheimer’s treatments.
This webinar is free to attend and is presented in plain language. You will have the opportunity have questions.
For more information on the study, visit: https://tdn.alz.to/research_study/dominantly-inherited-alzheimer-network-trial-primary-prevention-dian-tu-002/
This webinar is presented in partnership with the Toronto Dementia Research Alliance
About the Presenters
Tina Le is a Clinical Research Coordinator at Sunnybrook Research Institute, focusing on Alzheimer’s disease and frontotemporal dementia studies with Dr. Mario Masellis. She previously worked at Centricity Research, handling studies in endocrine, vaccine, and obesity areas, including diabetic retinopathy, RSV, and chronic kidney disease. Tina holds a Bachelor’s from Ryerson University (2020) and a Postgraduate Certificate in Clinical Research from Humber College (2022). She earned her Clinical Research Coordinator certification in 2024. Tina is dedicated to advancing research for effective treatments.
Anjana Elayathamby is a Clinical Research Coordinator and Research Nurse at Sunnybrook Research Institute, specializing in Alzheimer’s disease and frontotemporal dementia studies with Dr. Mario Masellis. A registered nurse from Quebec, she pursued a Bachelor of Science from the University of Toronto, with minors in Biomedical Ethics and Health Humanities. With over eight years of experience in neurology and neurosurgery, Anjana has a strong background in clinical care, research, and patient-centered practice. She is passionate about advancing compassionate, equitable healthcare and research to improve the lives of those affected by neurodegenerative diseases.
